50 mg tablets are light beige, round, film-coated tablets with "112" on one side
Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems
Does Januvia interact with other diabetes drugs, such as Ozempic, Trulicity, Farxiga, or Jardiance? Januvia is known to interact with certain diabetes drugs
Either increases effects of the other by pharmacodynamic synergism
JANUVIA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
It belongs to the drug class dipeptidyl
Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar
Your doctor may adjust your dose if needed
Januvia (sitagliptin) is a brand-name oral tablet that’s prescribed for type 2 diabetes
In the 24-week, placebo-controlled factorial study of initial therapy with JANUVIA in combination with metformin, the incidence of hypoglycemia was 0
Common interactions include alopecia among females, and blood glucose increased among males
saxagliptin
dizziness, nausea; or
Janumet XR is the extended-release (ER) version that you take once a day
Your doctor may change your dose of JANUVIA based on the results of your blood tests
When used in addition to diet and exercise, Januvia has been shown to improve blood sugar control (your A1C)
Here's the full text article: Safety and Efficacy of Treatment with Sitagliptin or Glipizide in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A 2-year Study
Glipizide is taken once or twice a day (typical daily dose: 5 mg to 40 mg) Glyburide is taken once or twice a day (typical daily dose: 1
5 to 40 mg per day; total daily doses above 15 mg/day should be divided and administered twice a day
d
When metformin does not adequately control blood sugar, another medication must be added
Whereas body weight increased in subjects given glipizide (by 1
The other study compared Januvia with metformin, used on their own, in 1,058 patients; The CHMP decided that Januvia’s benefits are greater than its risks and recommended that it be given marketing authorisation The decrease in bodyweight in the groups given sitagliptin in combination with metformin was similar to that in the groups given metformin alone or placebo
7%)